Diabetic Retinopathy: Effects of Melatonin Treatment on Visual Functions and Circadian Rhythm
Last updated on July 2021Recruitment
- Recruitment Status
- Enrolling by invitation
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Circadian Dysrhythmia
- Circadian Rhythm Sleep Disorder, Unspecified Type
- Diabetic Retinopathy
- Melatonin
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Crossover AssignmentIntervention Model Description: A Double-blind, randomized, placebo-controlled trialMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Masking Description: Melatonin and placebo tablets are identicle in terms of taste, colour, tablet-size etc. The tablets are packed and masked by external manufacturer.Primary Purpose: Treatment
Participation Requirements
- Age
- Between 40 years and 75 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03478306
- Collaborators
- Steno Diabetes Center Copenhagen
- Investigators
- Principal Investigator: Shakoor Ba-Ali Department of Ophthalmology, Rigshospitalet-Glostrup
Get Well Soon